Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma

被引：0
|
作者：
Meiling Sun
Huaijun Ji
Ning Xu
Peng Jiang
Tao Qu
Yu Li
机构：
[1] Shandong University,Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine
[2] Weihai Municipal Hospital,Department of Respiratory Medicine
[3] Weihai Municipal Hospital,Department of Thoracic Surgery
来源：
BMC Cancer | / 22卷
关键词：
Immune checkpoint inhibitors (ICIs); PD-L1 inhibitor; NSCLC; Objective response rate; Disease control rate; Median progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
    Sun, Meiling
    Ji, Huaijun
    Xu, Ning
    Jiang, Peng
    Qu, Tao
    Li, Yu
    BMC CANCER, 2022, 22 (01)
  • [2] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis
    Meng, Lingbin
    Cao, Biwei
    Ji, Rui
    Chen, Dung-Tsa
    Laber, Damian A.
    Shafique, Michael
    JOURNAL OF CANCER, 2023, 14 (17): : 3169 - 3175
  • [4] Real-world data in the era of immune checkpoint inhibitors
    Narita, Yukiya
    ANNALS OF ONCOLOGY, 2021, 32 : S250 - S250
  • [5] REAL-WORLD OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA (PSCC) RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICI)
    Zhuang, Tony
    Goyal, Subir
    Brown, Jacqueline
    Carthon, Bradley
    Kucuk, Omer
    McClintock, Greta
    Yantorni, Lauren
    Bilen, Mehmet
    Master, Viraj
    Nazha, Bassel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A498 - A499
  • [6] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    Luke S. McLean
    Annette M. Lim
    Mathias Bressel
    Alesha A. Thai
    Danny Rischin
    Drugs & Aging, 2024, 41 : 271 - 281
  • [7] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [8] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    McLean, Luke S.
    Lim, Annette M.
    Bressel, Mathias
    Thai, Alesha A.
    Rischin, Danny
    DRUGS & AGING, 2024, 41 (03) : 271 - 281
  • [9] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [10] The Impact of MTAP loss on response to immune checkpoint inhibitors in stage IV NSCLC: A prospective real-world analysis
    El-Helali, A.
    Ko, E. y-l.
    Wong, C. H. L.
    Lecoultre, M.
    Chiu, M. K. L.
    Ho, I.
    Leung, D.
    Lee, A. W. M.
    Lee, V. H. F.
    ANNALS OF ONCOLOGY, 2024, 35
12345